Skip to content
10-K

Annual Report

AMICUS THERAPEUTICS, INC.

0001178879-26-000005

← back to feed
Filed
Feb 20, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 12, 2026 314M sh
Shares Diluted FY 2025 · Dec 31, 2025 308.36M sh
Shares Diluted FY 2025 · Dec 31, 2024 304.38M sh
Shares Diluted FY 2025 · Dec 31, 2023 295.16M sh
Capex FY 2025 · Dec 31, 2025 $3.3M
Capex FY 2025 · Dec 31, 2024 $3.55M
Capex FY 2025 · Dec 31, 2023 $7.44M
Operating Cash Flow FY 2025 · Dec 31, 2025 $33.15M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$33.89M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$69.09M
Long Term Debt FY 2025 · Dec 31, 2025 $392.66M
Long Term Debt FY 2025 · Dec 31, 2024 $390.11M
Cash And Equivalents FY 2025 · Dec 31, 2025 $214.01M
Cash And Equivalents FY 2025 · Dec 31, 2024 $213.75M
Cash And Equivalents FY 2025 · Dec 31, 2023 $246.99M
Stockholders Equity FY 2025 · Dec 31, 2025 $274.24M
Stockholders Equity FY 2025 · Dec 31, 2024 $194.05M
Stockholders Equity FY 2025 · Dec 31, 2023 $160.17M
Current Liabilities FY 2025 · Dec 31, 2025 $237.83M
Current Liabilities FY 2025 · Dec 31, 2024 $148.7M
Total Liabilities FY 2025 · Dec 31, 2025 $675.63M
Total Liabilities FY 2025 · Dec 31, 2024 $590.99M
Current Assets FY 2025 · Dec 31, 2025 $676.17M
Current Assets FY 2025 · Dec 31, 2024 $504.74M
Total Assets FY 2025 · Dec 31, 2025 $949.87M
Total Assets FY 2025 · Dec 31, 2024 $785.03M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.09
Eps Diluted FY 2025 · Dec 31, 2024 −$0.18
Eps Diluted FY 2025 · Dec 31, 2023 −$0.51
Eps Basic FY 2025 · Dec 31, 2025 −$0.09
Eps Basic FY 2025 · Dec 31, 2024 −$0.18
Eps Basic FY 2025 · Dec 31, 2023 −$0.51
Sga Expense FY 2025 · Dec 31, 2025 $383.49M
Sga Expense FY 2025 · Dec 31, 2024 $323.38M
Sga Expense FY 2025 · Dec 31, 2023 $275.27M
Net Income FY 2025 · Dec 31, 2025 −$27.11M
Net Income FY 2025 · Dec 31, 2024 −$56.11M
Net Income FY 2025 · Dec 31, 2023 −$151.58M
Operating Income FY 2025 · Dec 31, 2025 $32.79M
Operating Income FY 2025 · Dec 31, 2024 $24.88M
Operating Income FY 2025 · Dec 31, 2023 −$77.21M
Gross Profit FY 2025 · Dec 31, 2025 $561.28M
Gross Profit FY 2025 · Dec 31, 2024 $475.35M
Gross Profit FY 2025 · Dec 31, 2023 $362.03M
Revenue FY 2025 · Dec 31, 2025 $634.21M
Revenue FY 2025 · Dec 31, 2024 $528.3M
Revenue FY 2025 · Dec 31, 2023 $399.36M